Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 140 for your search:
Cancer Type/Condition:
Brain tumor, child: General & other
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
0 to 30
Sponsor:
Other
Protocol IDs:
EUDRACT 2005-002618-40
, BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723
2.
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
3 to 21 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-ACNS0331
, ACNS0331, NCT00085735
3.
Maternal Problem-Solving in Childhood Cancer
Phase:
Phase III
Type:
Educational/Counseling/Training, Supportive care
Status:
Active
Age:
0 to 18
Sponsor:
NCI, Other
Protocol IDs:
RO1 CA098964-02
, RSRB 09840, NCT00234793
4.
Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Phase:
Phase III
Type:
Educational/Counseling/Training
Status:
Active
Age:
11 to 24
Sponsor:
NCI, NINR
Protocol IDs:
COG-ANUR0631
, NCT00305851
5.
Effect of Diazoxide on the Obesity Secondary to Hypothalamic-Pituitary Lesions
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
6 to 18
Sponsor:
Other
Protocol IDs:
P040701
, NCT00306683
6.
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 3
Sponsor:
NCI
Protocol IDs:
COG-ACNS0334
, ACNS0334, NCT00336024
7.
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 10 at diagnosis
Sponsor:
Other
Protocol IDs:
CHLA-HEAD-START-III
, CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
8.
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
3 to 21
Sponsor:
NCI
Protocol IDs:
COG-ACNS0332
, ACNS0332, NCT00392327
9.
Treatment of Tumors of the Choroid Plexus Epithelium
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2005-0398
, NCT00500890
10.
SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours
Phase:
Phase III
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
3 to 25
Sponsor:
Other
Protocol IDs:
SCRT Trial
, NCT00517959
11.
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, or Osteosarcoma
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
1 to 18
Sponsor:
NCI
Protocol IDs:
COG-ACCL0431
, ACCL0431, NCT00716976
12.
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Phase:
Phase III
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
Under 3
Sponsor:
Other
Protocol IDs:
CCLG-CNS-2007-09
, CCLG CNS 2007 09, EU-20835, NCT00683319
13.
The Effectiveness of the Neutropenic Diet in Pediatric Cancer Patients
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
1 to 21
Sponsor:
Other
Protocol IDs:
06-08-367
, NCT00726934
14.
Efficacy and Safety of RAD001 in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CRAD001M2301
, NCT00789828
15.
Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
3 to 21 at diagnosis
Sponsor:
NCI, Other
Protocol IDs:
CDR0000367486
, SJCRH-SJMB03, NCT00085202
16.
A Phase I/II Study of the Photon Radiosurgery System
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
2 to 32
Sponsor:
Other
Protocol IDs:
CNS 0201
, NCT00179907
17.
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
1 to 120
Sponsor:
Other
Protocol IDs:
R01 CA 89395-01
, Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
18.
A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
1 to 17
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AP23573-07-110
, SUN08-01, NCT00704054
19.
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 to 25
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
CHNMC-07053
, 07053, CA180 121, NCT00788125
20.
PF-02341066 in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 to 21
Sponsor:
NCI
Protocol IDs:
COG-ADVL0912
, ADVL0912, NCT00939770
21.
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
3 to 25
Sponsor:
NCI, Other
Protocol IDs:
CDR0000437085
, SJCRH-SJHG04, GENENTECH-OSI3160s, NCT00124657
22.
Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
1 to 30
Sponsor:
Other
Protocol IDs:
OHSU-5056
, OHSU SOL-08131-L, NCT00983398
23.
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
5 to 75
Sponsor:
Other
Protocol IDs:
31717
, PSHCI #09-045, NCT00990496
24.
Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
3 to 20
Sponsor:
Other
Protocol IDs:
SIOP-EPENDYMOMA-99
, AIEOP-EPENDYMOMA-99, CCLG-EPENDYMOMA-99, EU-99001, NCT00004224
25.
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
3 to 30 at initial diagnosis
Sponsor:
Other
Protocol IDs:
CHP-693
, CHP-IRB-2001-12-2301, NCI-V01-1680, NCT00031590
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
